CHEMBL1341582
IC50 values of 1.634 +/- 0.066 microM against AChE and 0.0285 +/- 0.019 microM against BuChE. inhibited Abeta1-42 aggregation. See also small molecule antagonist of the CRF-binding protein and CRF-R2 receptor complex in high throughput screens as compiled in PubChem
General
Type : Sulfur Compound, Pyrazole
Chemical_Nomenclature : 5-methyl-4-(4-nitrophenyl)sulfanyl-2-phenylpyrazol-3-amine
Canonical SMILES : CC1=NN(C(=C1SC2=CC=C(C=C2)[N+](=O)[O-])N)C3=CC=CC=C3
InChI : InChI=1S\/C16H14N4O2S\/c1-11-15(23-14-9-7-13(8-10-14)20(21)22)16(17)19(18-11)12-5-3-2-4-6-12\/h2-10H,17H2,1H3
InChIKey : YXPSKDWPGKXZED-UHFFFAOYSA-N
Other name(s) : MLS000418426 || SMR000264885 || BDBM90259
MW : 326.4
Formula : C16H14N4O2S
CAS_number :
PubChem : 2317975
UniChem : YXPSKDWPGKXZED-UHFFFAOYSA-N
Target
Families : CHEMBL1341582 ligand of proteins in family
BCHE
Protein :
human-BCHE
References (1)
| Title : Design and development of sulfenylated 5-aminopyrazoles as inhibitors of acetylcholinesterase and butyrylcholinesterase: exploring the implication for Abeta(1-42) aggregation inhibition in Alzheimer's disease - Rani_2025_RSC.Med.Chem__ |
| Author(s) : Rani P , Chahal S , Ranolia A , Kiran , Kumar D , Kataria R , Kumar P , Singh D , Duhan A , Jha V , Wahajuddin M , Joshi G , Sindhu J |
| Ref : RSC Med Chem , : , 2025 |
| Abstract : |
| PubMedSearch : Rani_2025_RSC.Med.Chem__ |
| PubMedID: 40256309 |